Gabriela Gomez

Gabriela Gomez is an epidemiologist/health economist at the Amsterdam Institute for Global Health and Development and Department of Global Health, University of Amsterdam. She leads operational research projects evaluating the impact of prevention programs for key populations in sub-Saharan Africa. These programs include HIV prevention for truck drivers and sex workers in Zambia, Zimbabwe and South Africa; cardiovascular disease prevention in slums in Kenya and rural Nigeria; expansion of antiretroviral services (PrEP and immediate treatment) for female sex workers in South Afrcia, and ante-natal care interventions in rural Nigeria.

She is currently a visiting research fellow in the Department of Global Health and Development at the London School of Hygiene and Tropical Medicine, where she has developed a cost-effectiveness model to evaluate the scale-up of new shortened regimens for first line treatment of TB in Brazil, Bangladesh, Tanzania and South Africa. She is currently part of the TB Modelling and Analysis consortium, funded by the Bill and Melinda Gates Foundation, where she works on several projects evaluating the feasibility of End TB Strategy’s global goals in China, South Africa, and India.

During the last three years, she has been a consultant in the division of Reproductive Health and Research at the World Health Organisation. Gabriela obtained her PhD in Infectious Disease Epidemiology from Imperial College London and overall she has over ten years’ experience working with vulnerable populations in marginalized environments.